p27kip1 Antisense-induced proliferative activity of rat corneal endothelial cells.
OBJECTIVE
To determine whether antisense downregulation of p27(kip1) will overcome G(1)-phase arrest and promote cell cycle progression in rat corneal endothelial cells (CECs).


METHODS
Confluent cultures of rat CECs were incubated for 24 hours in the presence of p27(kip1) antisense (AS) oligonucleotides (oligoS) using nonliposomal lipid transfection. Control cultures were incubated under one of the following conditions: no oligos or lipid-containing buffer, lipid-containing buffer alone, or lipid-containing buffer plus missense (MS) p27(kip1) oligo. Viability was tested by a cell-viability assay after 0, 24, 48, and 72 hours. After postincubation for 0, 24, 48, or 72 hours, cultures were fixed and immunostained for p27(kip1), to test for downregulation, or for Ki67 or BrdU, to detect actively cycling cells. Western blot and immunocytochemistry (ICC) studies were conducted to determine the effect of p27(kip1) antisense treatment on the relative protein level and subcellular localization of several cell cycle proteins, including cyclin-D1, -E, -A, and -B1; CDK2 and -4; p21(cip1); and p15(INK4b). Proliferation was determined by direct counting of propidium iodide (PI) or 4',6'-diamino-2-phenylindole (DAPI)-stained cells.


RESULTS
Viability was not significantly affected by lipid-based oligo transfection for up to 48 hours, after which a decline was noted. The protein level of p27(kip1) was reduced after AS transfection in a time-dependent manner. Nuclear staining for p27(kip1) was greatly reduced in CECs incubated with AS oligo. No change in p27(kip1) levels was observed in controls at any time point tested. p27(kip1) AS oligo transfection increased cyclin-D1, -E, -A, and -B1 protein levels, and all cyclins were localized to the nucleus. No changes in protein level were observed for CDK2, CDK4, p21(cip1), or p15(INK4B). A time-dependent increase in the relative number of Ki67- and BrdU-positive cells was noted in CECs incubated with AS oligo. In contrast, no to few Ki67- or BrdU-positive cells were observed in CECs incubated with MS oligo or the buffer-treated control cells. The percentage increase in the number of cells transfected with AS oligo increased with time, compared with that of cells transfected with MS oligo.


CONCLUSIONS
Treatment with p27(kip1) antisense oligonucleotides followed by postincubation in 10% FBS lowers endogenous p27(kip1) protein levels and promotes proliferation in confluent cultures of rat CECs.
Kikuchi
Michiharu
M
Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, USA.
Harris
Deshea L
DL
Obara
Yoshitaka
Y
Senoo
Tadashi
T
Joyce
Nancy C
NC
D000818:Animals; D015153:Blotting, Western; D001973:Bromodeoxyuridine / Q000378:metabolism; D018797:Cell Cycle Proteins / Q000235:genetics* / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival; D002478:Cells, Cultured; D050760:Cyclin-Dependent Kinase Inhibitor p27; D015536:Down-Regulation; D004728:Endothelium, Corneal / Q000166:cytology* / Q000378:metabolism; D018014:Gene Transfer Techniques; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000378:metabolism; D008297:Male; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014162:Transfection; D025521:Tumor Suppressor Proteins / Q000235:genetics* / Q000378:metabolism
C493962:Cdkn1b protein, rat; D018797:Cell Cycle Proteins; D019394:Ki-67 Antigen; D016376:Oligonucleotides, Antisense; D025521:Tumor Suppressor Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27; D001973:Bromodeoxyuridine